Search results
Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) Expected to Post Q1 2024 Earnings of ($0.83) Per Share
ETF DAILY NEWS· 5 days agoApellis Pharmaceuticals, Inc. (NASDAQ:APLS – Free Report) – Research analysts at Wedbush raised their Q1 2024 earnings per share estimates for Apellis Pharmaceuticals in a note issued to investors ...